Showing results (51-60 of 87) with videos related to

Sort By:
Pageof 9
Experimental Hematology|March 1, 1992
Detection of BCR/ABL translocation by polymerase chain reaction in leukemic progenitor cells (ALL-CFU) from patients with acute lymphoblastic leukemia (ALL)M A Allieri, S Fabrega, H Ozsahin, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|June 1, 2000
PDGF-mediated chemoattraction of hepatic stellate cells by bile duct segments in cholestatic liver injuryN Kinnman, R Hultcrantz, V Barbu, et al.
The Journal of Clinical Investigation|May 1, 1994
Anti-tumor necrosis factor modulates anti-CD3-triggered T cell cytokine gene expression in vivoC Ferran, F Dautry, S Mérite, et al.
Experimental Cell Research|September 1, 1987
c-myc oncogene expression inhibits the initiation of myogenic differentiationN Denis, S Blanc, M P Leibovitch, et al.
European Journal of Immunology|April 1, 1997
Mice heterozygous for a deletion of the tumor necrosis factor-alpha and lymphotoxin-alpha genes: biological importance of a nonlinear response of tumor necrosis factor-alpha to gene dosageF Amiot, O Boussadia, S Cases, et al.
The Journal of Biological Chemistry|July 15, 1994
Reduced insulin receptor expression and function in human colonic Caco-2 cells by ras and polyoma middle T oncogenesS Baron-Delage, J Capeau, V Barbu, et al.
Biochemical Pharmacology|February 1, 1987
Effect of AY 9944 and chlorpromazine on Concanavalin A-induced stimulation of human lymphocytesV Barbu, J C Mazière, F Maindrault, et al.
Experimental Hematology|July 1, 1983
The role of serum lipoproteins on the in vitro proliferative potential of human hematopoietic progenitors CFUC and CFUEL Douay, V Barbu, C Baillou, et al.
Fundamental & Clinical Pharmacology|January 11, 2000
Lymphocyte P-glycoprotein expression and activity before and after rifampicin in manL Becquemont, M Camus, V Eschwege, et al.
Leukemia & Lymphoma|September 6, 2007
Simultaneous regression of Philadelphia chromosome and multiple nonrecurrent clonal chromosomal abnormalities with imatinib mesylate in a patient autografted 22 years before for chronic myelogenous leukemiaJ Van Den Akker, P Coppo, M F Portnoï, et al.
Pageof 9